This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated RNF168 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-RNF168 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~65 kDa | |
| Observed band | ~65 kDa | |
| Gel | 10–12% | |
| Negative control | siRNA / KO lysate |
| PTM | Phosphorylated + Ubiquitinated | |
| Caveat | Phosphorylation-induced mobility shift | |
| Regulation | LPS-induced | |
| Isoform | 1 isoform(s) |
Literature-validated Western blot parameters for RNF168 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human Raji . After Electrophoresis, proteins were transferred to a Nitrocellulose membrane at 150mA for 50-90 minutes. Blocked the membrane with 5% Non-fat Milk/ TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-RNF168 antigen affinity purified polyclonal antibody (Catalog # A01224-1) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for RNF168 at approximately 65KD. The expected band size for RNF168 is at 65KD |
| Gel % | 10–12% |
| Load | 50ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 65 kDa |
RNF168 has a 65 kDa predicted mass and runs at ~65 kDa observed, since it lacks glycosylation, dimerization, or cleavage; phosphorylation may cause minor shifts.
| single sharp band at ~65 kDa | matches RNF168's predicted mass with no glycosylation, cleavage, or dimerization to alter migration |
| band enriched in nuclear fraction, faint in cytoplasmic fraction | RNF168 is a nuclear protein that localizes to chromatin and DNA double-strand break sites |
| slight upward shift or faint doublet near 65 kDa | reflects the phosphorylated versus unphosphorylated pool of RNF168, which carries 8 annotated phosphosites |
| no higher-molecular-weight band around 130 kDa | RNF168 functions as a monomer with no inter-chain disulfide bonds, so no dimer band is expected |
| single full-length band with no smaller cleaved fragment | RNF168 has no signal peptide or propeptide, so no precursor-to-mature processing occurs |
| Predicted mass (65 kDa, 571 aa) | sets the baseline migration position, consistent with the ~65 kDa band typically observed |
| Phosphorylation at 8 residues (e.g. Ser70, Ser134, Thr362, Ser411/414/415, Ser470) | can cause a slight upward mobility shift or faint doublet without changing the true mass, especially when DNA damage signaling is active |
| Monomer with no disulfide bonds | no higher-molecular-weight dimer band should appear under reducing or non-reducing SDS-PAGE |
| No signal peptide or propeptide | protein runs as a single full-length mature species with no smaller cleaved fragment |
| Nuclear/chromatin localization | band recovery depends on efficient nuclear lysis; incomplete chromatin extraction under-represents true signal |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | standard whole-cell lysis under-extracts the chromatin-bound nuclear pool of RNF168 | use a dedicated nuclear/chromatin extraction buffer with sonication or benzonase before loading |
| Weak or no signal | RNF168 is expressed at low basal levels and is most enriched at sites of DNA damage | induce DNA damage (e.g. ionizing radiation) prior to lysis and include a damage-induced positive control |
| Band higher than expected | hyperphosphorylation of RNF168 after DNA damage signaling can retard mobility on the gel | compare untreated versus damage-induced lysates or treat lysate with phosphatase to resolve the shift |
| Band lower than expected | incomplete solubilization of the chromatin-bound fraction leaves only a smaller soluble pool detected | confirm complete nuclear lysis and load nuclear-enriched fractions rather than cytoplasmic extracts |
| Multiple bands | a mixed population of phosphorylated and unphosphorylated RNF168 can resolve as closely spaced bands | run a phosphatase-treated control lane alongside untreated lysate to confirm the bands collapse to one |
| Fragments below expected size | proteolytic degradation of the nuclear extract during lysis or storage | lyse fresh in cold buffer with protease inhibitors and keep samples on ice throughout |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for RNF168, answered from its protein features.
BosterBio's RNF168 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Our recommended anti-RNF168 antibody for Western blot is a best-performing, extensively cited reagent, thoroughly validated through rigorous testing and orthogonally cross-validated against negative tissue controls and complementary detection methods, ensuring confident, specific, and reproducible RNF168 detection.
Which to pick: Only one Boster RNF168 antibody is catalogued, A01224-1, which includes an authentic Western blot validation image on SDS-PAGE, making it the clear—and only—choice available for your RNF168 Western blot experiments.